These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
146 related articles for article (PubMed ID: 17879370)
1. Hormone replacement therapy and lung cancer risk in Chinese. Chen KY; Hsiao CF; Chang GC; Tsai YH; Su WC; Perng RP; Huang MS; Hsiung CA; Chen CJ; Yang PC; Cancer; 2007 Oct; 110(8):1768-75. PubMed ID: 17879370 [TBL] [Abstract][Full Text] [Related]
2. Hormone replacement therapy as a risk factor for non-small cell lung cancer: results of a case-control study. Ramnath N; Menezes RJ; Loewen G; Dua P; Eid F; Alkhaddo J; Paganelli G; Natarajan N; Reid ME Oncology; 2007; 73(5-6):305-10. PubMed ID: 18493157 [TBL] [Abstract][Full Text] [Related]
3. Fumes from meat cooking and lung cancer risk in Chinese women. Seow A; Poh WT; Teh M; Eng P; Wang YT; Tan WC; Yu MC; Lee HP Cancer Epidemiol Biomarkers Prev; 2000 Nov; 9(11):1215-21. PubMed ID: 11097230 [TBL] [Abstract][Full Text] [Related]
4. Reproductive factors, hormone use, estrogen receptor expression and risk of non small-cell lung cancer in women. Schwartz AG; Wenzlaff AS; Prysak GM; Murphy V; Cote ML; Brooks SC; Skafar DF; Lonardo F J Clin Oncol; 2007 Dec; 25(36):5785-92. PubMed ID: 18089876 [TBL] [Abstract][Full Text] [Related]
5. A case-control study of lifestyle and lung cancer associations by histological types. Kubik A; Zatloukal P; Tomasek L; Dolezal J; Syllabova L; Kara J; Kopecky P; Plesko I Neoplasma; 2008; 55(3):192-9. PubMed ID: 18348651 [TBL] [Abstract][Full Text] [Related]
6. [A case-control study of the risk factors of lung cancer in Beijing, Tianjin, Shanghai, Chongqing metropolitan areas]. Yu M; Rao K; Chen Y Zhonghua Yu Fang Yi Xue Za Zhi; 2000 Jul; 34(4):227-31. PubMed ID: 11860937 [TBL] [Abstract][Full Text] [Related]
7. Dose-response relationship between cooking fumes exposures and lung cancer among Chinese nonsmoking women. Yu IT; Chiu YL; Au JS; Wong TW; Tang JL Cancer Res; 2006 May; 66(9):4961-7. PubMed ID: 16651454 [TBL] [Abstract][Full Text] [Related]
8. Hormone replacement therapy and survival in lung cancer in postmenopausal women in a rural population. Huang B; Carloss H; Wyatt SW; Riley E Cancer; 2009 Sep; 115(18):4167-75. PubMed ID: 19526591 [TBL] [Abstract][Full Text] [Related]
9. Hormone replacement therapy and lung cancer risk: a case-control analysis. Schabath MB; Wu X; Vassilopoulou-Sellin R; Vaporciyan AA; Spitz MR Clin Cancer Res; 2004 Jan; 10(1 Pt 1):113-23. PubMed ID: 14734459 [TBL] [Abstract][Full Text] [Related]
10. Variability of breast cancer risk in observational studies of hormone replacement therapy: a meta-regression analysis. Garbe E; Levesque L; Suissa S Maturitas; 2004 Mar; 47(3):175-83. PubMed ID: 15036487 [TBL] [Abstract][Full Text] [Related]
11. Hormone replacement therapy and risk for coronary heart disease. Data from the CORA-study--a case-control study on women with incident coronary heart disease. Windler E; Zyriax BC; Eidenmüller B; Boeing H Maturitas; 2007 Jul; 57(3):239-46. PubMed ID: 17292571 [TBL] [Abstract][Full Text] [Related]
12. [A case-control study on relationship between body mass index and lung cancer in non-smoking women]. Xiang Y; Gao Y; Zhong L; Jin F; Sun L; Cheng J; Zhai Y Zhonghua Yu Fang Yi Xue Za Zhi; 1999 Jan; 33(1):9-12. PubMed ID: 11864446 [TBL] [Abstract][Full Text] [Related]
13. [Selection of population-based controls in pair-matched case-control study analyzing risk factors for lung cancer]. Yu M; Rao K; Chen Y Zhonghua Yu Fang Yi Xue Za Zhi; 2000 May; 34(3):165-8. PubMed ID: 11860927 [TBL] [Abstract][Full Text] [Related]
14. [Studies on relationship between passive smoking and lung cancer in non-smoking women]. Zheng S; Fan R; Wu Z Zhonghua Yu Fang Yi Xue Za Zhi; 1997 May; 31(3):163-5. PubMed ID: 9812596 [TBL] [Abstract][Full Text] [Related]
15. Lack of evidence for effect modification by estrogen of association between body mass index and colorectal cancer risk among postmenopausal women. Wang Y; Jacobs EJ; Teras LR; Pavluck AL; Rodriguez C; Thun MJ; Calle EE Cancer Causes Control; 2007 Oct; 18(8):793-9. PubMed ID: 17619155 [TBL] [Abstract][Full Text] [Related]
16. [Influence of menstrual and reproductive factors on the risk of lung cancer]. Brenner AV; Wang ZY; Kleinerman RA; Wang LD; Metayer C; Lubin JH Zhonghua Liu Xing Bing Xue Za Zhi; 2004 Jul; 25(7):590-3. PubMed ID: 15308039 [TBL] [Abstract][Full Text] [Related]
17. Circulating adiponectin levels and expression of adiponectin receptors in relation to lung cancer: two case-control studies. Petridou ET; Mitsiades N; Gialamas S; Angelopoulos M; Skalkidou A; Dessypris N; Hsi A; Lazaris N; Polyzos A; Syrigos C; Brennan AM; Tseleni-Balafouta S; Mantzoros CS Oncology; 2007; 73(3-4):261-9. PubMed ID: 18424891 [TBL] [Abstract][Full Text] [Related]
18. Age and menopausal effects of hormonal birth control and hormone replacement therapy in relation to breast cancer risk. Shantakumar S; Terry MB; Paykin A; Teitelbaum SL; Britton JA; Moorman PG; Kritchevsky SB; Neugut AI; Gammon MD Am J Epidemiol; 2007 May; 165(10):1187-98. PubMed ID: 17337757 [TBL] [Abstract][Full Text] [Related]
19. Use of exogenous hormones by women and lung cancer: evidence from the Royal College of General Practitioners' Oral Contraception Study. Elliott AM; Hannaford PC Contraception; 2006 Apr; 73(4):331-5. PubMed ID: 16531161 [TBL] [Abstract][Full Text] [Related]
20. Hormone replacement therapy, reproductive history, and colorectal adenomas: data from the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial (United States). Purdue MP; Mink PJ; Hartge P; Huang WY; Buys S; Hayes RB Cancer Causes Control; 2005 Oct; 16(8):965-73. PubMed ID: 16132805 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]